Compound

D0976 | lasalocid sodium

Molecular Formula C34H53NaO8
Molecular Weight 612.8
Structure

Toxicity Dose Time Species Model Method Action Positive criterion Reference
MEMBRANE POTENTIAL 1.14±0.07 human qHTS-HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 1.38 human HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 1.30±0.29 rat hepatocytes MMP assay decrease IC50 163

Pictogram Signal Statements Precautionary Statement Codes
Danger

Aggregated GHS information provided by 193 companies from 2 notifications to the ECHA C&L Inventory.


Reported as not meeting GHS hazard criteria by 1 of 193 companies. For more detailed information, please visit ECHA C&L website


Of the 1 notification(s) provided by 192 of 193 companies with hazard statement code(s):


H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]


Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.


P264, P270, P301+P310, P321, P330, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.)


  • 2,3-Cresotic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-, monosodium salt. (-)- 25999-20-6 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methylbenzoic acid monosodium salt, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S*),5alpha,6beta))-
    AKOS025311506 Avatec BDBM79589
    Benzoic acid, 6-((3R,4S,5S,7R)-7-((2S,3S,5S)-5-ethyl-5-((2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl-, monosodium salt Benzoic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl-, monosodium salt, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S*),5alpha,6beta))- Benzoic acid,6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methy
    Bovate 20 Bovatec Bovatec 150FP
    CAS-25999-20-6 CHEMBL1489769 CS-5930
    DSSTox_CID_25895 DSSTox_GSID_45895 DSSTox_RID_81207
    DTXSID9045895 EINECS 247-400-3 HMS2097F17
    HMS2235P08 HY-B1071A J-016217
    Lasalocid (sodium) Lasalocid A Na salt Lasalocid A Sodium
    Lasalocid A Sodium Salt (Solution in acetonitrile 0.2mg/2ml) Lasalocid A monosodium salt Lasalocid A sodium 100 microg/mL in Acetonitrile
    Lasalocid A sodium salt Lasalocid A sodium salt solution, 100 mug/mL in acetonitrile, VETRANAL(TM), analytical standard; Lasalocid A sodium salt solution, ~100 microg/ml in acetonitrile
    Lasalocid sodium Lasalocid sodium salt Lascaloid
    MCULE-6219687714 MLS001173429 MLS001304052
    MLS001334026 MLS001334027 MLS006011597
    MT 2007 MT2007 NCGC00095029-01
    NP167 NSC 243046 NSC243046
    Q27292230 R987 Ro 2-2985
    SMR000538906 Sodium lasalocid Sodium lasalocid A
    Tox21_111396 UNII-W2S5C71Y3G W2S5C71Y3G
    cid_6426773 sodium;6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoate

    CAS Number 25999-20-6
    PubChem Compound 6426773